Categories: Non classé

At the heart of dermal matrix remodeling by VitroScreen

VitroScreen m-Dermis (scaffold free organoid) is produced by human primary dermal fibroblasts and with donors of different age : it has shown interesting features during 21 days in culture conditions.

By precisely mimicking ECM production in vivo, the micro-dermis model resulted to be an unique and  innovative tool for active ingredients screening on dermal matrix deposition and remodeling by VitroScreen Multiple Endpoints Approach that includes also 3D imaging techniques.

 

Contact

Marisa Méloni

marisa.meloni@vitroscreen.com
Via Mosé Bianchi,103

20149 Milano

 

Recent Posts

Final program Cosmetotest on May 14-15, 2025, Preclinical and clinical testing Symposium in Lyon & Hybrid

LIVE & HYBRID All you need to know about preclinical and clinical testing is at…

Save the Date: April 28th, Testing Trends Webinar – Feedback on the Testing and Lab Zone x in-cosmetics global

👉 Register: Exclusive webinar in English April 28th 2025 at 3:00 PM [CEST]   We…

Save the Date: May 8th – What’s trending in cosmetics, A.I and other things! Webinar via Personal Care Insights

HOW AI IS SHAPING BIO-BASED BEAUTY AND PERSONALIZED PRODUCTS 📆 May, 8th 2025 ⏱️ 16:00…